This website uses cookies to improve your browsing experience. By continuing to use this site, you consent to our use of cookies. You can manage your cookie preferences in our Cookie Policy.

Skip to content
Highlights
  • A Skin Test, a New Kind of Pill and Other Parkinson’s Advances Emerge From MDS Congress
  • Apple’s ARKit Facial Tracking Framework and an iPad Pro are Helping Researchers in Germany to Develop Facial Tracking for Parkinson’s disease.
  • This Week in Parkinson’s: New Research Looks Beyond Symptoms to Better Measure, Track and Treat the Disease
  • Medicare 2026 Plans
    Navigating Medicare with Parkinson’s: What’s covered, What isn’t and the Cost Differences
  • Gene Therapy Image
    After a year of regulatory whiplash, first Huntington’s gene therapy heads to FDA review
  • EU Approves Extended-Release Parkinson’s Drug Hopledo, Widening Options for Motor Fluctuations

Category: Research News

The Research News section of The Movement Disorder Journal and News highlights emerging scientific discoveries and medical studies related to neurological movement disorders such as Parkinson’s disease, Essential Tremor, and related conditions. The articles translate complex scientific findings into accessible reporting, covering topics ranging from new biomarkers for Parkinson’s detection to sleep disorders associated with movement conditions and evolving treatment approaches. By examining recently published studies and clinical research, the section aims to keep readers informed about the latest developments in neuroscience while helping patients, caregivers, and the public understand how new research may shape future diagnosis, treatments, and care.

  • Home
  • Research News
Apple’s ARKit Facial Tracking Framework and an iPad Pro are Helping Researchers in Germany to Develop Facial Tracking for Parkinson’s disease.
Clinical TrialsMDS-UPDRSResearch News

Apple’s ARKit Facial Tracking Framework and an iPad Pro are Helping Researchers in Germany to Develop Facial Tracking for Parkinson’s disease.

Apple’s ARKit and an iPad are making strides tracking facial movement in Parkinson’s disease patients in the latest study published in npj Parkinson’s disease.
Chris DennySeptember 28, 2026September 28, 2026
EU Approves Extended-Release Parkinson’s Drug Hopledo, Widening Options for Motor Fluctuations
Drug TrialsIn the NewsLatest in HealthResearch News

EU Approves Extended-Release Parkinson’s Drug Hopledo, Widening Options for Motor Fluctuations

The European Commission has granted marketing authorization for Hopledo, an extended-release levodopa-carbidopa capsule already sold in the United States as Crexont, clearing the way for…
Chris DennySeptember 21, 2026

Posts pagination

1 2 … 29 Next
he National Parkinson's Institute
The Parkinson's Plan
Our World with Words and Film LLC 2026
Our World in Words and Film LLC 2026
  • Facebook
  • Bluesky
  • X
  • YouTube
  • Threads
  • Pinterest
  • Instagram
  • LinkedIn
  • TikTok

Copyright © 2016 Our World in Words and Film
X